OXYGENTA PHARMACEUTICAL
|
The Current P/S Ratio of OXYGENTA PHARMACEUTICAL is 1.93.
Share Price | ₹58.7 | Oct 10,2025 |
Market Cap | ₹217.2 Cr | |
Sales-TTM | ₹112.6 Cr | TTM-Standalone Results |
Price/Sales | 1.93x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of OXYGENTA PHARMACEUTICAL
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹217.2 Cr] as on Oct 10,2025
(/) Sales [ ₹112.6 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 1.93x ]
Thus, for OXYGENTA PHARMACEUTICAL , the investors are currently willing to pay '1.93 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of OXYGENTA PHARMACEUTICAL !
The chart below summarizes the trend in P/S Ratio of OXYGENTA PHARMACEUTICAL over the last five years.
Historical PS (Price/Sales) ratio chart of OXYGENTA PHARMACEUTICAL
PS Ratio Performance Analysis for OXYGENTA PHARMACEUTICAL
- OXYGENTA PHARMACEUTICAL 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 0.94x.
- OXYGENTA PHARMACEUTICAL 's operated at median p/e ratio of 0.56x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, OXYGENTA PHARMACEUTICAL 's p/e ratio peaked in Mar2024 at 2.45x.
- OXYGENTA PHARMACEUTICAL 's p/e ratio hit its five-year low in Mar2021 of 0x.
How does OXYGENTA PHARMACEUTICAL 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
OXYGENTA PHARMACEUTICAL | 112.6 | 1.93 | 217.2 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 53,777.1 | 7.45 | 400,893.0 |
DIVIS LABORATORIES LTD | 9,652.0 | 17.82 | 171,976.0 |
CIPLA LTD | 27,811.2 | 4.54 | 126,137.0 |
TORRENT PHARMACEUTICALS LTD | 11,835.0 | 10.12 | 119,712.0 |
DR REDDYS LABORATORIES LTD | 33,519.9 | 3.15 | 105,562.0 |
MANKIND PHARMA LTD | 12,956.2 | 7.83 | 101,491.0 |
ZYDUS LIFESCIENCES LTD | 23,607.7 | 4.23 | 99,964.3 |
LUPIN LTD | 23,375.9 | 3.83 | 89,510.8 |
AUROBINDO PHARMA LTD | 32,024.8 | 2.05 | 65,665.4 |
ABBOTT INDIA LTD | 6,589.9 | 9.73 | 64,121.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs OXYGENTA PHARMACEUTICAL 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 1.93x |
Max industry PS | 17.82x |
Median industry PS | 4.54x |
Average industry PS | 6.61x |
You may also like the below Video Courses